Panax SRL
Panax reported total assets of 99,320 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Aug 2026).
The score of Panax shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +332 % Total assets +281 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Panax's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Aug 2026
- Year ended 31 Dec 2024filed on 11 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
Panax's financial analysis
- Solvency74.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Panax
Panax's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.840.537
- VAT number
- BE1002840537
- Peppol
- Registered · 0208:1002840537 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Nov 2023
- Registered office
- 1780 Wemmel
- Latest accounts
- 2025 · filed on 03 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Panax (SRL) has been based in Wemmel since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 19,163 € and equity of 74,310 €; its revenue is not published. Its solvency stands at 74.8%, above the median of its sector (44.2%).
Companies similar to Panax
Companies in the same business, of comparable size and area, outside its group.
- AVA-Rose Retail sale of pharmaceutical products Jette · balance sheet 381,859 €
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Curasan Retail sale of pharmaceutical products Zwalm · balance sheet 103,974 €
- Kato VAN Vooren Retail sale of pharmaceutical products Dendermonde · balance sheet 88,886 €
- VAN Aelst Leonie Retail sale of pharmaceutical products Beernem · balance sheet 86,688 €
- BSB Pharma Retail sale of pharmaceutical products Berchem-Sainte-Agathe · balance sheet 118,927 €
- NT Farma Retail sale of pharmaceutical products Mouscron · balance sheet 56,255 €
- Apocurae Retail sale of pharmaceutical products Kortemark · balance sheet 124,948 €
Frequently asked questions about Panax
What is the revenue of Panax?
Panax files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Panax?
In Belgium, the VAT number is the company number prefixed with BE: BE1002840537 for Panax, if the company is VAT-registered. Its company number (CBE) is 1002.840.537.
Where is the registered office of Panax?
According to the CBE register, the registered office of Panax is in 1780 Wemmel.
What is the equity of Panax?
At the close of the 2025 financial year, the equity of Panax amounts to 74,310 €, a solvency of 74.8% of total assets.
Who manages Panax?
The register lists 1 active mandates at Panax. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Panax
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →